Johnson & Johnson working on coronavirus treatment with US government, Belgium researchers
Janssen Pharmaceutical Cos. and the US government will share costs in discovering the treatment
FOX Business' Susan Li reports Apple took 60 percent off the Dow due to closed factories impacted by coronavirus, but it's 'only temporary.'
Johnson & Johnson said it will work with the Rega Institute for Medical Research in Belgium to identify antiviral, therapeutic candidates to treat the disease caused by the novel coronavirus, in an expanded effort with the Department of Health and Human Services.
GET FOX BUSINESS ON THE GO BY CLICKING HERE
Janssen Pharmaceutical Cos., a J&J company, and the department's Biomedical Advanced Research and Development Authority will share costs in discovering the treatment, the company said Tuesday.
J&J last week said it will work with HHS to accelerate the development of a potential coronavirus vaccine.
CORONAVIRUS CLAIMS LIFE OF HOSPITAL DIRECTOR IN HARD-HIT WUHAN
J&J shares rose 0.2 percent.